Portfolio company
SiccaNova Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops small-molecule therapeutics to treat medical conditions involving dryness, including xerostomia and dry eye, for patients with unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Roca Therapeutics
The company develops small molecule therapies for patients with severe ocular diseases and cancers such as uveal melanoma.
Seranova Bio
This biotechnology company develops autoantibody-based therapeutics and discovery platforms for pharmaceutical partners and clinicians treating autoimmune diseases, cancer and neurodegenerative disorders.
SFA Theraputics
This biopharmaceutical company develops oral small-molecule drugs for patients suffering from autoimmune diseases, chronic inflammatory conditions, and various types of liver cancer.
Healome Therapeutics
The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.
Healome
Healome Therapeutics develops eye-drop matrix technology that restructures on the ocular surface to provide long-acting lubrication and drug delivery for patients with eye diseases.
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Bikam Pharmaceuticals
This drug discovery company develops small-molecule therapies for patients with ophthalmic diseases such as retinitis pigmentosa.
Nuvectis Pharma
This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.
